Starpharma Quote - SPL

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.10

Bid

0.096

Ask

0.10

Volume

73,121

0.097 Day's Range 0.10

0.086 52 Week Range 0.145

Market Cap

40.885M

Previous Close

0.097

Open

0.098

Last Trade

63297

0.1

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

393,299

Shares Outstanding

408,852,447

Dividend Yield

PE Ratio

-5.00

Earnings Per Share (EPS)

-0.02

Revenue

13.82M

Net Profit

-8.17M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.starpharma.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Starpharma Holdings Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker SPL. The last closing price for Starpharma was AUD0.10. Over the last year, Starpharma shares have traded in a share price range of AUD 0.086 to AUD 0.145.

Starpharma currently has 408,852,447 shares outstanding. The market capitalization of Starpharma is AUD39.66 million. Starpharma has a price to earnings ratio (PE ratio) of -5.00.

Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

MELBOURNE, Australia, June 24, 2021 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, OTCQX: SPHRY), based in...

Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal...

Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal...

Starpharma creates slow release soluble DEP remdesivir nanoparticle

DEP® remdesivir has been created to expand the potential application of remdesivir, by creating a long-acting...

Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

Product development activities for SPL7013, repurposed as an antiviral nasal spray, are now well advanced with formulations developed, a...

Starpharma’s SPL7013 Shows Significant Activity Against SARS-CoV-2 (coronavirus)

Starpharma’s antiviral dendrimer, SPL7013, has been shown to have significant activity against SARS-CoV-21 (coronavirus), which causes COVID-19...

Starpharma: Commencement of Phase 1 Trial for AZD0466 Utilising DEP® Delivery Technology

AstraZeneca has commenced its first-in-human/phase 1 clinical trial for AZD0466 in the US in a range of cancers AZD0466 utilises Starpharma’s...

Starpharma Signs Second Oncology Agreement With AstraZeneca

Starpharma has signed a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product...

VivaGel® Condom Receives Final Regulatory Approval in Japan

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that the VivaGel® condom has received final regulatory approval and is now able to be...

Starpharma Licenses VivaGel® BV to Mundipharma for Europe

Starpharma licenses VivaGel® BV to Mundipharma for Europe, Russia, CIS1 and the balance of Latin America to be marketed as part of the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-9.09090909091	0.11	0.11	0.096	505901	0.10049606	DE
4	0	0	0.1	0.125	0.096	581330	0.11147129	DE
12	-0.01	-9.09090909091	0.11	0.13	0.096	393299	0.10947438	DE
26	0.0065	6.95187165775	0.0935	0.13	0.088	485243	0.10320032	DE
52	-0.03	-23.0769230769	0.13	0.145	0.086	500122	0.10355352	DE
156	-0.73	-87.9518072289	0.83	1	0.086	515514	0.26003613	DE
260	-0.79	-88.7640449438	0.89	2.52	0.086	597113	0.83238312	DE

SPL - Frequently Asked Questions (FAQ)

What is the current Starpharma share price?

The current share price of Starpharma is AUD 0.10

How many Starpharma shares are in issue?

Starpharma has 408,852,447 shares in issue

What is the market cap of Starpharma?

The market capitalisation of Starpharma is AUD 39.66M

What is the 1 year trading range for Starpharma share price?

Starpharma has traded in the range of AUD 0.086 to AUD 0.145 during the past year

What is the PE ratio of Starpharma?

The price to earnings ratio of Starpharma is -5

What is the cash to sales ratio of Starpharma?

The cash to sales ratio of Starpharma is 2.96

What is the reporting currency for Starpharma?

Starpharma reports financial results in AUD

What is the latest annual turnover for Starpharma?

The latest annual turnover of Starpharma is AUD 13.82M

What is the latest annual profit for Starpharma?

The latest annual profit of Starpharma is AUD -8.17M

What is the registered address of Starpharma?

The registered address for Starpharma is 4-6 SOUTHAMPTON CRESENT, ABBOTSFORD, MELBOURNE, VICTORIA, 3067

What is the Starpharma website address?

The website address for Starpharma is www.starpharma.com

Which industry sector does Starpharma operate in?

Starpharma operates in the PHARMACEUTICAL DIVERSIFIED sector

Symbol	Price	Vol.
EUROBEuropean Lithium Limited	AUD 0.002 (100.00%)	11.2M
H2GGreenHy2 Ltd	AUD 0.006 (100.00%)	8.4M
SFGSeafarms Group Limited	AUD 0.002 (100.00%)	1.7M
RLTRenergen Limited	AUD 0.75 (66.67%)	96.83k
GTRGTI Energy Ltd	AUD 0.003 (50.00%)	1.5M
TSOOATesoro Gold Ltd	AUD 0.003 (-70.00%)	150k
ATVOActiveport Group Ltd	AUD 0.001 (-50.00%)	255k
ASPAspermont Limited	AUD 0.003 (-40.00%)	2.48M
LRDOLord Resources Ltd	AUD 0.004 (-33.33%)	400k
MRDMount Ridley Mines Ltd	AUD 0.002 (-33.33%)	400k
BCBBowen Coking Coal Limited	AUD 0.005 (-9.09%)	66.96M
VAUVault Minerals Ltd	AUD 0.455 (5.81%)	66.69M
TMKTMK Energy Ltd	AUD 0.003 (-14.29%)	47.99M
PNRPantoro Limited	AUD 0.16 (6.67%)	44.69M
NMGNew Murchison Gold Ltd	AUD 0.0155 (3.33%)	43.43M

Symbol

Price

Vol.